Journey Medical Corporation (DERM) Financials

DERM Assets vs Liabilities

Date	Assets	Liabilities
March 31, 2026	91.5 million	60.7 million
Dec. 31, 2025	94.6 million	62.7 million
Sept. 30, 2025	85.2 million	59.3 million
June 30, 2025	81.2 million	61.9 million

DERM Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.

Date	Free Cash Flow	Stock based compensation
March 31, 2026	2.9 million	989000
Dec. 31, 2025	-6.4 million	1.8 million
Sept. 30, 2025	-2.4 million	1.9 million
June 30, 2025	-942000	1.3 million

DERM Net Income

No data available :(

DERM Cash and Debt

Graph available only for paid members. Upgrade to see it.

Date	Cash	Debt	Capital Lease
March 31, 2026	27.2 million	22.9 million	94000
Dec. 31, 2025	24.1 million	18000	119000
Sept. 30, 2025	24.9 million	19.5 million	142000
June 30, 2025	20.3 million	21.4 million	165000

DERM Shares Outstanding

Graph available only for paid members. Upgrade to see it.

Date	Shares Outstanding
March 31, 2026	27.3 million
Dec. 31, 2025	24.5 million
Sept. 30, 2025	25.0 million
June 30, 2025	23.3 million

DERM Expenses

Graph available only for paid members. Upgrade to see it.

Date	Capex	R&D	G&A	S&M
March 31, 2026	-	-	10.1 million	-
Dec. 31, 2025	-	154000	9.9 million	-
Sept. 30, 2025	-	287000	12.1 million	-
June 30, 2025	-	-	11.9 million	-

DERM Cost of Revenue

Graph available only for paid members. Upgrade to see it.

Date	Revenue	Cost of Revenue
March 31, 2026	16.0 million	7.3 million
Dec. 31, 2025	16.1 million	6.5 million
Sept. 30, 2025	17.6 million	5.8 million
June 30, 2025	15.0 million	6.0 million

DERM Revenue by Segment

Graph available only for paid members. Upgrade to see it.

DERM

Price: $6.06

52 week price:

4.31

9.56

Earnings Per Share: -0.37 USD

Exchange: NCM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Country: United States

Volume: 25200

Ebitda: -176.2 million

Market Capitalization: 168.9 million

Links:

DERM on Yahoo Finance